EMA review of suicide risk for Ozempic, Saxenda extended to other GLP-1 receptor agonists | Biospace

Pictured: The EMA building at its old headquarters in London/iStock, Lubo Ivanko

Pictured: The EMA building at its old headquarters in London/iStock, Lubo Ivanko The European Medicines Agency has extended its review of a potential suicide risk associated with Novo Nordisk’s Ozempic and Saxenda to other GLP-1 receptor agonists used for weight loss and the treatment of type 2 diabetes. The review was initiated by the Icelandic … Read more

Antidepressants, antipsychotics and benzos all increase suicide attempts in a new study

A new study a JAMA network open found that antidepressants do not prevent suicide. The researchers concluded that antidepressants, antipsychotics and benzodiazepines were all associated with increased suicide attempts in people with borderline personality disorder (BPD). Mood stabilizers had no effect on suicide attempt rates. ADHD stimulant drugs were the only drug class associated with … Read more